Petra Minder
Impact in
- Virology top 10%
- HIV Research and Treatment
Papers in
-
- CRISPR and Genetic Engineering 2
- Angiogenesis and VEGF in Cancer 1
- Glycosylation and Glycoproteins Research 1
-
- Cell Adhesion Molecules Research 4
- Co-authors
- Ewa Zając (2 shared papers)James P. Quigley (2 shared papers)Elena I. Deryugina (2 shared papers)Anna Juncker‐Jensen (1 shared paper)Bernhard Schweighofer (1 shared paper)Tatyana A. Kupriyanova (1 shared paper)Bruce E. Torbett (5 shared papers)Mi Ae Park (1 shared paper)
- Journals
- Blood (2 papers)Biological Chemistry (2 papers)Molecular Therapy — Methods & Clinical Development (1 paper)Journal of Biological Chemistry (1 paper)Molecular Therapy — Nucleic Acids (1 paper)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Petra Minder
10 papers receiving 512 citations
Peers
Comparison fields: 5 of 72
- Virology 46
- Business and International Management 16
- Immunology 145
- Cancer Research 75
- Immunology and Allergy 27
Countries citing papers authored by Petra Minder
This map shows the geographic impact of Petra Minder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Minder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Minder more than expected).
Fields of papers citing papers by Petra Minder
This network shows the impact of papers produced by Petra Minder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Minder. The network helps show where Petra Minder may publish in the future.
Co-authors
The 25 scholars most cited alongside Petra Minder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 214 | |
| 2 | 2015 | 113 | |
| 3 | 2015 | 65 | |
| 4 | 2022 | 38 | |
| 5 | 2018 | 35 | |
| 6 | 2012 | 29 | |
| 7 | 2018 | 11 | |
| 8 | 2016 | 10 | |
| 9 | 2018 | 2 | |
| 10 | 2016 | 1 |
About Petra Minder
Petra Minder is a scholar working on Molecular Biology, Immunology and Allergy, Cancer Research, Surgery and Cell Biology, having authored 10 papers that have together received 518 indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cellular transport and secretion (2 papers), Pancreatic function and diabetes (2 papers), CRISPR and Genetic Engineering (2 papers), Immune cells in cancer (1 paper), Angiogenesis and VEGF in Cancer (1 paper) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Virology (46 citations), Business and International Management (16 citations), Immunology (145 citations), Cancer Research (75 citations) and Immunology and Allergy (27 citations). Petra Minder has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include Ewa Zając, James P. Quigley, Elena I. Deryugina, Anna Juncker‐Jensen, Bernhard Schweighofer, Tatyana A. Kupriyanova, Bruce E. Torbett, Mi Ae Park, HyunJun Kang and Igor I. Slukvin. Their work appears in journals such as Blood, Biological Chemistry, Molecular Therapy — Methods & Clinical Development, Journal of Biological Chemistry and Molecular Therapy — Nucleic Acids.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.